Matches in Wikidata for { <http://www.wikidata.org/entity/Q37109512> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q37109512 description "article científic" @default.
- Q37109512 description "article scientifique" @default.
- Q37109512 description "articolo scientifico" @default.
- Q37109512 description "artigo científico" @default.
- Q37109512 description "artículu científicu espublizáu en 2008" @default.
- Q37109512 description "bilimsel makale" @default.
- Q37109512 description "scientific article published on 14 March 2008" @default.
- Q37109512 description "vedecký článok" @default.
- Q37109512 description "vetenskaplig artikel" @default.
- Q37109512 description "videnskabelig artikel" @default.
- Q37109512 description "vědecký článek" @default.
- Q37109512 description "wetenschappelijk artikel" @default.
- Q37109512 description "wissenschaftlicher Artikel" @default.
- Q37109512 description "наукова стаття, опублікована в березні 2008" @default.
- Q37109512 description "научни чланак" @default.
- Q37109512 description "مقالة علمية نشرت في 14 مارس 2008" @default.
- Q37109512 name "Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections" @default.
- Q37109512 name "Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections" @default.
- Q37109512 name "Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections" @default.
- Q37109512 type Item @default.
- Q37109512 label "Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections" @default.
- Q37109512 label "Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections" @default.
- Q37109512 label "Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections" @default.
- Q37109512 prefLabel "Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections" @default.
- Q37109512 prefLabel "Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections" @default.
- Q37109512 prefLabel "Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections" @default.
- Q37109512 P1433 Q37109512-B8D1482A-6777-44A5-88DD-F09C5BBCA0E3 @default.
- Q37109512 P1476 Q37109512-BB96F4CE-BCBD-45B0-9C2A-67F56D0C2AB1 @default.
- Q37109512 P2093 Q37109512-14D27BE6-EC24-4B4C-B7EC-A4317E198826 @default.
- Q37109512 P2093 Q37109512-3DB5EEA6-97CC-4669-A0F0-98A9685C0691 @default.
- Q37109512 P2093 Q37109512-53B74850-3472-4A08-A83B-D7542B3FF363 @default.
- Q37109512 P2093 Q37109512-94FB5FBF-1326-44E8-8D7D-BEA083EDF464 @default.
- Q37109512 P304 Q37109512-1F13F8F7-03FB-444A-8787-752DF224D9A0 @default.
- Q37109512 P31 Q37109512-69914245-3B73-45E8-80C2-460987CC8EB8 @default.
- Q37109512 P31 Q37109512-e2686723-e8fe-4c84-b58f-6aed500e3a13 @default.
- Q37109512 P356 Q37109512-F3E8F3A8-2652-4BCE-9962-97D1A321197E @default.
- Q37109512 P407 Q37109512-23F9CF39-7D4E-4AE6-B381-955151ACB21C @default.
- Q37109512 P433 Q37109512-4A8DDC60-B923-4EEB-B992-BDC4A6CD47B4 @default.
- Q37109512 P478 Q37109512-95DDAB9A-E857-4A7B-9CC6-5CDBA829F1E1 @default.
- Q37109512 P577 Q37109512-49954B09-0E6B-475C-8E48-E5BAFC4372A9 @default.
- Q37109512 P698 Q37109512-871DC431-C119-4FCE-A186-488D3F03734B @default.
- Q37109512 P921 Q37109512-4E75F128-BBBA-431C-9B20-79A8F2681801 @default.
- Q37109512 P921 Q37109512-7627185A-75A7-4E5B-AFD0-7A85B07EF1E3 @default.
- Q37109512 P356 JM800038G @default.
- Q37109512 P698 18338841 @default.
- Q37109512 P1433 Q900316 @default.
- Q37109512 P1476 "Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections" @default.
- Q37109512 P2093 "Douglas K Hutchinson" @default.
- Q37109512 P2093 "Michael R Barbachyn" @default.
- Q37109512 P2093 "Peter R Manninen" @default.
- Q37109512 P2093 "Steven J Brickner" @default.
- Q37109512 P304 "1981-1990" @default.
- Q37109512 P31 Q13442814 @default.
- Q37109512 P31 Q7318358 @default.
- Q37109512 P356 "10.1021/JM800038G" @default.
- Q37109512 P407 Q1860 @default.
- Q37109512 P433 "7" @default.
- Q37109512 P478 "51" @default.
- Q37109512 P577 "2008-03-14T00:00:00Z" @default.
- Q37109512 P698 "18338841" @default.
- Q37109512 P921 Q411377 @default.
- Q37109512 P921 Q857288 @default.